アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/07/24 | 2,098 | 2,107.5 | 2,084 | 2,103 | +25.5 | +1.2% | 4,289,800 |
2023/07/21 | 2,070 | 2,092.5 | 2,062.5 | 2,077.5 | +7 | +0.3% | 5,051,600 |
2023/07/20 | 2,069 | 2,082 | 2,052 | 2,070.5 | +12.5 | +0.6% | 6,572,000 |
2023/07/19 | 2,038 | 2,059 | 2,024.5 | 2,058 | +43 | +2.1% | 5,295,100 |
2023/07/18 | 2,011 | 2,028.5 | 2,004 | 2,015 | +10 | +0.5% | 5,961,100 |
2023/07/14 | 1,983 | 2,029 | 1,983 | 2,005 | -3.5 | -0.2% | 6,373,400 |
2023/07/13 | 2,006.5 | 2,024.5 | 1,999 | 2,008.5 | -13.5 | -0.7% | 4,349,000 |
2023/07/12 | 2,040 | 2,042 | 2,001.5 | 2,022 | -27.5 | -1.3% | 5,957,400 |
2023/07/11 | 2,052.5 | 2,061 | 2,041 | 2,049.5 | +11.5 | +0.6% | 5,615,400 |
2023/07/10 | 2,060 | 2,071 | 2,020 | 2,038 | -23 | -1.1% | 7,562,300 |
2023/07/07 | 2,060 | 2,077.5 | 2,028 | 2,061 | +9 | +0.4% | 7,733,500 |
2023/07/06 | 2,092 | 2,092.5 | 2,042 | 2,052 | -32 | -1.5% | 5,945,600 |
2023/07/05 | 2,090 | 2,098.5 | 2,081.5 | 2,084 | +0.5 | ±0% | 4,655,800 |
2023/07/04 | 2,128.5 | 2,138.5 | 2,077.5 | 2,083.5 | -61 | -2.8% | 6,426,100 |
2023/07/03 | 2,158.5 | 2,161.5 | 2,139.5 | 2,144.5 | -4.5 | -0.2% | 4,442,900 |
2023/06/30 | 2,150.5 | 2,156.5 | 2,131 | 2,149 | -7 | -0.3% | 6,723,200 |
2023/06/29 | 2,197.5 | 2,206 | 2,147 | 2,156 | -36.5 | -1.7% | 6,260,900 |
2023/06/28 | 2,165 | 2,199 | 2,162 | 2,192.5 | +30 | +1.4% | 5,208,900 |
2023/06/27 | 2,179 | 2,188 | 2,152.5 | 2,162.5 | -26.5 | -1.2% | 4,276,700 |
2023/06/26 | 2,182.5 | 2,196 | 2,157.5 | 2,189 | -6 | -0.3% | 5,081,400 |
2023/06/23 | 2,211.5 | 2,219 | 2,173 | 2,195 | -10.5 | -0.5% | 6,833,000 |
2023/06/22 | 2,203 | 2,219.5 | 2,195 | 2,205.5 | +1 | ±0% | 5,907,100 |
2023/06/21 | 2,227 | 2,238 | 2,196 | 2,204.5 | -27.5 | -1.2% | 5,708,900 |
2023/06/20 | 2,252 | 2,256.5 | 2,213.5 | 2,232 | -42 | -1.8% | 4,666,900 |
2023/06/19 | 2,295 | 2,305 | 2,266 | 2,274 | -18 | -0.8% | 4,217,900 |
2023/06/16 | 2,257 | 2,297.5 | 2,252.5 | 2,292 | +33.5 | +1.5% | 7,166,600 |
2023/06/15 | 2,273.5 | 2,279 | 2,244 | 2,258.5 | -27.5 | -1.2% | 4,996,000 |
2023/06/14 | 2,288.5 | 2,297 | 2,273 | 2,286 | -4.5 | -0.2% | 4,545,200 |
2023/06/13 | 2,296 | 2,299.5 | 2,280 | 2,290.5 | +13.5 | +0.6% | 4,027,700 |
2023/06/12 | 2,275 | 2,294 | 2,260 | 2,277 | +17.5 | +0.8% | 3,802,900 |
2023/06/09 | 2,258 | 2,275 | 2,239.5 | 2,259.5 | +25.5 | +1.1% | 7,586,000 |
2023/06/08 | 2,260 | 2,269 | 2,223 | 2,234 | -26 | -1.2% | 4,659,400 |
2023/06/07 | 2,296.5 | 2,312.5 | 2,256 | 2,260 | -45 | -2% | 5,306,400 |
2023/06/06 | 2,265 | 2,307.5 | 2,257 | 2,305 | +17.5 | +0.8% | 4,760,000 |
2023/06/05 | 2,273 | 2,288 | 2,251 | 2,287.5 | +58.5 | +2.6% | 4,996,000 |
2023/06/02 | 2,242.5 | 2,253.5 | 2,205 | 2,229 | -7 | -0.3% | 5,511,800 |
2023/06/01 | 2,220 | 2,237 | 2,210 | 2,236 | +28.5 | +1.3% | 5,162,900 |
2023/05/31 | 2,236 | 2,239.5 | 2,204.5 | 2,207.5 | -56.5 | -2.5% | 12,763,000 |
2023/05/30 | 2,292 | 2,308.5 | 2,254 | 2,264 | -32 | -1.4% | 5,061,700 |
2023/05/29 | 2,321 | 2,340 | 2,287.5 | 2,296 | -23.5 | -1% | 8,062,800 |
2023/05/26 | 2,333.5 | 2,345 | 2,319.5 | 2,319.5 | -21.5 | -0.9% | 5,777,700 |
2023/05/25 | 2,318 | 2,360.5 | 2,308.5 | 2,341 | +17 | +0.7% | 6,222,900 |
2023/05/24 | 2,324.5 | 2,338 | 2,315.5 | 2,324 | -4.5 | -0.2% | 3,885,900 |
2023/05/23 | 2,336.5 | 2,343 | 2,305 | 2,328.5 | +19.5 | +0.8% | 6,152,400 |
2023/05/22 | 2,280 | 2,309 | 2,274 | 2,309 | +41 | +1.8% | 4,661,900 |
2023/05/19 | 2,250 | 2,271.5 | 2,244 | 2,268 | +24.5 | +1.1% | 4,586,300 |
2023/05/18 | 2,232.5 | 2,245.5 | 2,215 | 2,243.5 | +4.5 | +0.2% | 5,522,700 |
2023/05/17 | 2,219.5 | 2,246 | 2,216 | 2,239 | +20 | +0.9% | 5,070,700 |
2023/05/16 | 2,192 | 2,219 | 2,190 | 2,219 | +43 | +2% | 7,097,900 |
2023/05/15 | 2,148 | 2,176 | 2,128.5 | 2,176 | +47 | +2.2% | 6,107,400 |
201~
250
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,100円 | +2.9% | +72.2% | 4.90% | 90.32倍 | 1.70倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 416,500円 | +2.0% | +4.2% | 4.71% | 112.66倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 650,500円 | +6.0% | +131.3% | 1.84% | 14.13倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 714,400円 | +4.6% | +0.9% | 2.38% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 665,500円 | +1.7% | -2.9% | 2.40% | 44.42倍 | 2.18倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム